Contact: Katie Marquedant
Massachusetts General Hospital
Caption: The Jantibody fusion protein, combining an antibody fragment targeting an antigen found on tumor cells with an immune-response-inducing protein, MTBhsp70, activates dendritic cells against several tumor antigens and induces a number of T-cell-based immune responses.
Credit: Jianping Yuan, Ph.D., Massachusetts General Hospital Vaccine and Immunotherapy Center
Usage Restrictions: None
Related news release: Novel cancer vaccine holds promise against ovarian cancer, mesothelioma